| IPI00021842 - APOE, APOLIPOPROTEIN E PRECURSOR. | |
|---|---|
| Uniprot Accession: Q8TCZ8 | |
| Uniprot ID: Q8TCZ8_HUMAN | |
| Mapping: Chr 19, 50100879 - 50104489 | |
| Entrez Gene: 348 | |
| Entrez MapView: |
|
| +All IPI Database Cross References | |
| IPI records in this ortholog cluster (Cluster: MGI_ORTHOLOGY_289) |
|---|
| Rat: Apoe, APOLIPOPROTEIN E PRECURSOR. |
| Mouse: Apoe, APOLIPOPROTEIN E PRECURSOR. |
| Rat: Apoe, 18 KDA PROTEIN. |
| Human: APOE, APOLIPOPROTEIN E PRECURSOR. |
| GO Term | Aspect | Human | Mouse | Rat |
|---|---|---|---|---|
| chylomicron | C | IEA | IEA | IEA |
| Golgi apparatus | C | IDA | ||
| cytoplasm | C | TAS | ISS IDA | |
| extracellular region | C | NAS TAS | IEA | ISS IEA |
| extracellular space | C | RCA IDA IDA IDA IDA | ISS IDA | |
| extrinsic to external side of plasma membrane | C | IDA | ||
| cholesterol transporter activity | F | IDA | ||
| lipid binding | F | IEA | IEA | |
| apolipoprotein E receptor binding | F | NAS | ISS | |
| heparin binding | F | NAS | IEA | ISS IEA |
| antioxidant activity | F | NAS | ISS ISS | |
| beta-amyloid binding | F | IDA | ISS ISS | |
| lipid transporter activity | F | IEA | IEA | IDA IEA |
| phospholipid binding | F | TAS | ISS | |
| lipoprotein binding | F | IEA | IDA | ISS IEA |
| tau protein binding | F | TAS | ISS | |
| cholesterol metabolic process | P | IMP IMP | ISS | |
| cellular calcium ion homeostasis | P | IEA | IDA | ISS IEA |
| cholesterol catabolic process | P | IEA | IMP | ISS IEA |
| synaptogenesis | P | ISS | ||
| lipoprotein metabolic process | P | NAS | IEA | ISS IEA |
| response to reactive oxygen species | P | NAS | ISS | |
| neurite regeneration | P | TAS | ||
| axon regeneration | P | IGI | ||
| protein localization | P | IMP | ||
| cytoskeleton organization and biogenesis | P | TAS | ISS | |
| lipid transport | P | TAS | IEA IEA | IDA ISS IEA |
| synaptic transmission, cholinergic | P | TAS | ISS | |
| response to oxidative stress | P | IMP | ISS IEA | |
| circulation | P | NAS | ISS | |
| regulation of neuronal synaptic plasticity | P | TAS | ISS | |
| learning and/or memory | P | TAS | ISS | |
| induction of apoptosis | P | IDA | ISS ISS | |
| lipoprotein biosynthetic process | P | IGI | ||
| transport | P | IEA | ||
| protein tetramerization | P | IDA | ISS IEA | |
| cholesterol homeostasis | P | TAS | IMP IMP | ISS ISS |
| response to ethanol | P | IDA | ||
| cholesterol efflux | P | IMP IDA | ||
| regulation of axon extension | P | TAS | ISS | |
| intracellular transport | P | TAS | ISS | |
| vasodilation | P | IEA | IMP | ISS IEA |
| GO Graph Color Key: | Rat | Mouse | Human | Rat & Mouse | Mouse & Human | Rat & Human | Rat, Mouse & Human |
SVG image
| GO Graph Color Key: | Rat | Mouse | Human | Rat & Mouse | Mouse & Human | Rat & Human | Rat, Mouse & Human |
SVG image
| GO Graph Color Key: | Rat | Mouse | Human | Rat & Mouse | Mouse & Human | Rat & Human | Rat, Mouse & Human |
SVG image
| MP Term | Aspect | Human | Mouse | Rat |
|---|---|---|---|---|
| adipose tissue phenotype | MP | Un | ||
| cellular phenotype | MP | Un Un | ||
| skin/coat/nails phenotype | MP | Un Un | ||
| endocrine/exocrine gland phenotype | MP | Un | ||
| behavior/neurological phenotype | MP | Un Un Un | ||
| homeostasis/metabolism phenotype | MP | Un Un Un Un Un Un Un Un Un | ||
| immune system phenotype | MP | Un Un | ||
| muscle phenotype | MP | Un | ||
| renal/urinary system phenotype | MP | Un | ||
| nervous system phenotype | MP | Un Un Un Un Un | ||
| vision/eye phenotype | MP | Un | ||
| digestive/alimentary phenotype | MP | Un | ||
| cardiovascular system phenotype | MP | Un Un Un Un Un Un | ||
| hearing/vestibular/ear phenotype | MP | Un | ||
| hematopoietic system phenotype | MP | Un Un | ||
| no phenotypic analysis | MP | Un | ||
| growth/size phenotype | MP | Un Un | ||
| liver/biliary system phenotype | MP | Un | ||
| life span-post-weaning/aging | MP | Un Un Un |
| DO Term | Aspect | Human | Mouse | Rat |
|---|---|---|---|---|
| Cerebrovascular Disorders | D | ISS | ||
| Hypertriglyceridemia | D | ISSISS | ||
| Obesity | D | ISS | ||
| Hypercholesterolemia | D | ISS | ||
| Memory Disorders | D | ISS | ||
| Myocardial Infarction | D | ISS | ||
| Diabetes Mellitus, Experimental | D | IEP | ||
| Cardiomyopathy, Congestive | D | ISS | ||
| Myocardial Ischemia | D | ISS | ||
| Hyperlipoproteinemia Type III | D | ISS | ||
| Coronary Arteriosclerosis | D | ISSISS | ||
| Aortic Aneurysm, Abdominal | D | ISS | ||
| Hyperlipidemia, Familial Combined | D | ISSISS | ||
| Coronary Disease | D | ISS | ||
| Cerebral Infarction | D | ISS |
| PW Term | Aspect | Human | Mouse | Rat |
|---|---|---|---|---|
| altered lipoprotein metabolic pathway | W | ISS | ||
| Alzheimer disease pathway | W | IEA | ||
| lipoprotein metabolic pathway | W | ISS |
| KEGG Pathway | Human | Mouse | Rat |
|---|---|---|---|
| Alzheimer's disease (05010) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| Neurodegenerative Disorders (01510) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |